QA: Allarity Therapeutics Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860657_2024_Allarity_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001860657, Allarity Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,971,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,000
3 remainder_Assets 9,871,000
4 LiabilitiesCurrent 14,167,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 446,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,026,000
9 ResearchAndDevelopmentExpense 7,103,000
10 remainder_Expenses 83,000
11 remainder_Revenues 0
12 remainder_NetIncome 5,311,000
13 remainder_ComprehensiveNetIncome 310,000
  yvar yval
0 Assets 11,862,000
1 Liabilities 14,613,000
2 Expenses 17,212,000
3 Revenues 0
4 StockholdersEquity -2,751,000
5 NetIncome -11,901,000
6 ComprehensiveNetIncome -11,746,000
7 BaseVar 24,654,000
8 EconomicCapitalRatiobeforeLimitedLiability -1.34
9 EconomicCapitalRatio 1.22

Edgar->Model Mapping

Feature Distribution